After it was revealed that TRAF3 plays a powerful B cell-specific role in restraint of homeostatic survival2,4, it has become evident that this TRAF3 role renders it an important tumor suppressor for B cell malignancies, particularly MM and BCL9. This evidence concerns the gene BCL9 and Miyoshi myopathy.